Related Experiment Videos
[The blood-born viral infections]
1Department of Clinical Pathology, Showa University Fujigaoka Hospital, Yokohama.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|April 7, 1998
Summary
Establishing robust risk control systems is crucial for managing emerging infectious diseases transmitted via blood, such as HIV and viral hepatitis. Enhanced surveillance and rapid molecular diagnostics are vital for preventing hospital-acquired infections and ensuring patient safety.
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Background:
- Emerging and re-emerging infectious diseases pose significant public health risks, particularly those transmitted through blood, including HIV, HBV, and HCV.
- Blood-borne viral infections like cytomegalovirus (CMV) and Epstein-Barr virus (EBV) are major contributors to hospital-acquired infections.
- Despite extensive screening, a risk of transmission exists during the 'window period' before detection.
Purpose of the Study:
- To highlight the urgent need for effective risk control systems against blood-borne infectious diseases.
- To emphasize the importance of molecular diagnostics and inter-organizational communication for managing infectious disease risks.
- To discuss the evolving understanding of EBV-related diseases and their implications for transfusion and transplant recipients.
Main Methods:
- Review of current knowledge on blood-borne viral pathogens and hospital-acquired infections.
- Analysis of risks associated with blood transfusion and transplantation.
- Discussion of diagnostic and communication strategies for infectious disease control.
Main Results:
- Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) are primary agents of blood-borne viral infections.
- Epstein-Barr virus (EBV) is increasingly recognized for its association with serious conditions, necessitating monitoring in immunocompromised individuals.
- Co-infections with EBV and CMV can occur, and preventing prion infections and needle-stick injuries are critical control measures.
Conclusions:
- A networked communication system involving clinical laboratories, research institutes, and public health organizations is essential.
- Rapid diagnosis through molecular analysis is key to adequate and timely patient care.
- Proactive risk management strategies are necessary to mitigate the threat of emerging and re-emerging infectious diseases.